US OptionsDetailed Quotes
CRM241213P390000
- 37.80
- 0.000.00%
15min DelayClose Dec 13 16:00 ET
0.00High0.00Low
37.80Open37.80Pre Close0 Volume0 Open Interest390.00Strike Price0.00Turnover2726.63%IV0.60%PremiumDec 13, 2024Expiry Date35.69Intrinsic Value100Multiplier0DDays to Expiry2.11Extrinsic Value100Contract SizeAmericanOptions Type-0.9586Delta0.0046Gamma9.95Leverage Ratio-562.1939Theta0.0000Rho-9.54Eff Leverage0.0006Vega
Salesforce Stock Discussion
Sign in to post a comment
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
1
1
1
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drug...
+2
Over the past few weeks, industry leaders like $Salesforce (CRM.US)$ , $Intuit (INTU.US)$ , and $Snowflake (SNOW.US)$ have showcased how Al is reshaping their offerings.
Cybersecurity firms are no exception, demonstrating that innovation in security is keeping pace with broader enterprise trends.
As Al shifts from hype to application, a pivotal moment has emerged. Autonomous Al agents are driving enterprise innovation, automating pro...
Cybersecurity firms are no exception, demonstrating that innovation in security is keeping pace with broader enterprise trends.
As Al shifts from hype to application, a pivotal moment has emerged. Autonomous Al agents are driving enterprise innovation, automating pro...
7
1
The frenzy of artificial intelligence continues to soar. Recently, U.S. stock AI advertising marketing leader $Applovin (APP.US)$ have attracted global attention, with a stock price increase of over 850% since the beginning of the year, a market cap exceeding $127 billion, repeatedly hitting historic highs, and continuing the AI myth.
Read more: Why Are These AI Stocks Seeing Even Bigger Surges Than Nvidia This Year?
Citi has significantly increased its pric...
Read more: Why Are These AI Stocks Seeing Even Bigger Surges Than Nvidia This Year?
Citi has significantly increased its pric...
88
5
131
The S&P 500 is on track to close the year with a gain of around 28%, after setting 57 record highs this year.
At the moment, the Wall Street is partying like it’s 1998 as market optimism fuels gains unmatched since the 2000 dot-com bubble.
This bullish market momentum is so strong to a point where it seems like nothing will disrupt it. Well, is that really the case?
$Salesforce (CRM.US)$ $CrowdStrike (CRWD.US)$ $Nike (NKE.US)$ $Taiwan Semiconductor (TSM.US)$ $Advanced Micro Devices (AMD.US)$ $Johnson & Johnson (JNJ.US)$ $Disney (DIS.US)$ $Sea (SE.US)$ $Grab Holdings (GRAB.US)$ $iShares Bitcoin Trust (IBIT.US)$ $Intel (INTC.US)$ ...
At the moment, the Wall Street is partying like it’s 1998 as market optimism fuels gains unmatched since the 2000 dot-com bubble.
This bullish market momentum is so strong to a point where it seems like nothing will disrupt it. Well, is that really the case?
$Salesforce (CRM.US)$ $CrowdStrike (CRWD.US)$ $Nike (NKE.US)$ $Taiwan Semiconductor (TSM.US)$ $Advanced Micro Devices (AMD.US)$ $Johnson & Johnson (JNJ.US)$ $Disney (DIS.US)$ $Sea (SE.US)$ $Grab Holdings (GRAB.US)$ $iShares Bitcoin Trust (IBIT.US)$ $Intel (INTC.US)$ ...
From YouTube
27
in this video i reveal my entire moomoo stock portfolio! how much im up/dowm on every stock! once i buy a stock in here i can never sell it for the rest of my life! LMK ur thoughts
$DocuSign (DOCU.US)$ $Perion Network (PERI.US)$ $Disney (DIS.US)$ $BILL Holdings (BILL.US)$ $Vanguard S&P 500 ETF (VOO.US)$ $Salesforce (CRM.US)$
$DocuSign (DOCU.US)$ $Perion Network (PERI.US)$ $Disney (DIS.US)$ $BILL Holdings (BILL.US)$ $Vanguard S&P 500 ETF (VOO.US)$ $Salesforce (CRM.US)$
From YouTube
Investors will turn their focus on to Friday’s jobs report. This is the last big data that the Fed will digest before the FOMC meeting on 17 and 18 December. Investors will be hoping to get a clearer picture into the health of the labour market.
The market expectations is that nonfarm payroll will increase by 214,000 in November. However , a much hotter than expected number may not be welcomed.
$Crude Oil Futures(FEB5) (CLmain.US)$ $Salesforce (CRM.US)$ $Bank of America (BAC.US)$ $iShares Bitcoin Trust (IBIT.US)$ $Netflix (NFLX.US)$ $Cloudflare (NET.US)$ $MARA Holdings (MARA.US)$ $iShares Bitcoin Trust (IBIT.US)$ $iShares 20+ Year Treasury Bond ETF (TLT.US)$ $Taiwan Semiconductor (TSM.US)$ $Snap Inc (SNAP.US)$ $Citigroup (C.US)$ $Wells Fargo & Co (WFC.US)$ $Lemonade (LMND.US)$ $Block (SQ.US)$
The market expectations is that nonfarm payroll will increase by 214,000 in November. However , a much hotter than expected number may not be welcomed.
$Crude Oil Futures(FEB5) (CLmain.US)$ $Salesforce (CRM.US)$ $Bank of America (BAC.US)$ $iShares Bitcoin Trust (IBIT.US)$ $Netflix (NFLX.US)$ $Cloudflare (NET.US)$ $MARA Holdings (MARA.US)$ $iShares Bitcoin Trust (IBIT.US)$ $iShares 20+ Year Treasury Bond ETF (TLT.US)$ $Taiwan Semiconductor (TSM.US)$ $Snap Inc (SNAP.US)$ $Citigroup (C.US)$ $Wells Fargo & Co (WFC.US)$ $Lemonade (LMND.US)$ $Block (SQ.US)$
From YouTube
5
5
1
$C3.ai (AI.US)$ is scheduled to report its second-quarter fiscal 2025 results on 09 Dec 2024 after market close.
AI expects revenues between $88.6 million and $93.6 million for the fiscal second quarter. Consensus Estimate for revenues is pegged at $91.01 billion, suggesting 24.28% growth compared to what was reported in the same quarter one year ago.
The consensus mark for quarterly loss is pegged at 16 cents per share. AI re...
AI expects revenues between $88.6 million and $93.6 million for the fiscal second quarter. Consensus Estimate for revenues is pegged at $91.01 billion, suggesting 24.28% growth compared to what was reported in the same quarter one year ago.
The consensus mark for quarterly loss is pegged at 16 cents per share. AI re...
+3
24
2
No comment yet
10xStockPicks OP : This is the correctly edited research report. Previous article has a few typos. Special thanks to Fund manager John for his notes. Please do your own research. I firmly believe ESPR will be a solid bet.